Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Electroconductive Soft Microcarriers for Suspension Culture of Skeletal Muscle Cells.

Macromolecular bioscience·2026

Same author

CAR-T Cell-Derived Exosomes and Cancer Immunotherapy: Advancing Production and Delivery Through Biofabrication.

Biofabrication·2026

Same author

Editorial: Fiber-based biomaterials for tissue engineering and regenerative medicine.

Frontiers in bioengineering and biotechnology·2026

Same author

Pericardial fluid extracellular vesicles enhance angiogenesis and blunt cardiac fibrosis in coronary disease.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026

Same author

Microfluidic platforms for precision delivery of therapeutic cells in regenerative and personalized medicine.

Advanced drug delivery reviews·2026

Same author

On-Chip modeling of drug-gut interactions in Oral drug delivery.

Advanced drug delivery reviews·2026

Same journal

Inorganic nanoparticles for diagnostics, drug delivery and therapy for solid tumors.

Drug discovery today·2026

Same journal

HDAC11 as a potential therapeutic target for Alzheimer's disease.

Drug discovery today·2026

Same journal

From biologics to small-molecule modulators: The evolving landscape of interleukin-targeted therapeutics.

Drug discovery today·2026

Same journal

Targeting the GLP-1 receptor pathways for dual management of obesity and depression.

Drug discovery today·2026

Same journal

Chemical intervention strategies targeting MYC for cancer therapy.

Drug discovery today·2026

Same journal

How many protein pairs can we chemically target?

Drug discovery today·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Feb 27, 2026

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation

Published on: September 19, 2019

Microfluidic technologies for anticancer drug studies.

Karolina P Valente¹, Sultan Khetani², Ahmad R Kolahchi²

¹Department of Mechanical Engineering, University of Victoria, Victoria, BC, V8P 5C2, Canada; Center for Advanced Materials and Related Technologies, University of Victoria, Victoria, BC, V8P 5C2, Canada.

Drug Discovery Today

|July 8, 2017

Summary

This summary is machine-generated.

Microfluidic models offer a 3D tumor environment for studying cancer growth and drug efficacy, overcoming limitations of 2D cell cultures for better anticancer drug development.

More Related Videos

Microfluidic Device for Recreating a Tumor Microenvironment in Vitro

Microfluidic Device for Recreating a Tumor Microenvironment in Vitro

Published on: November 20, 2011

Clinical Microfluidic Chip Platform for the Isolation of Versatile Circulating Tumor Cells

Clinical Microfluidic Chip Platform for the Isolation of Versatile Circulating Tumor Cells

Published on: October 13, 2023

Related Experiment Videos

Last Updated: Feb 27, 2026

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation

Published on: September 19, 2019

Microfluidic Device for Recreating a Tumor Microenvironment in Vitro

Microfluidic Device for Recreating a Tumor Microenvironment in Vitro

Published on: November 20, 2011

Clinical Microfluidic Chip Platform for the Isolation of Versatile Circulating Tumor Cells

Clinical Microfluidic Chip Platform for the Isolation of Versatile Circulating Tumor Cells

Published on: October 13, 2023

Area of Science:

Oncology
Biotechnology
Microfluidics

Background:

Traditional 2D cell cultures fail to replicate complex tumor microenvironments.
Limitations include inability to mimic in vivo cancer cell interactions and physiological conditions.

Purpose of the Study:

To review microfluidic applications in anticancer drug studies.
To provide insights into future clinical uses of microfluidic systems for drug development.

Main Methods:

Utilizing microfluidic technology to create 3D tumor models.
Incorporating multiple cell types and mechanical/biochemical stimuli.
Replicating tumor conditions like drug transport, hypoxia, and interstitial pressure.

Main Results:

Microfluidic models provide a more accurate recapitulation of the 3D tumor environment.
These systems enable detailed studies of drug transport and tumor physiology.
Demonstrated potential for evaluating experimental therapeutics.

Conclusions:

Microfluidic platforms are valuable tools for advancing cancer research.
They enhance the preclinical evaluation of anticancer drugs.
Future clinical applications hold promise for personalized cancer therapy development.